Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How asymptomatic is asymptomatic primary hyperparathyroidism?

C Hasse1, H Sitter, S Bachmann

  • 1Department of Surgery, Philipps-University of Marburg, Germany. sitter@mailer.uni-marburg.de

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|August 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2024
Same author

Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay.

Physical review letters·2024
Same author

Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2024
Same author

Enhanced Production of Λ_{b}^{0} Baryons in High-Multiplicity pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} Baryon.

Physical review letters·2024
Same author

Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) Resonance.

Physical review letters·2024

Many patients with primary hyperparathyroidism (pHPT) who appear asymptomatic actually experience symptom improvement after parathyroidectomy (PTX). Truly asymptomatic pHPT patients are rare and cannot be predicted preoperatively.

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Neurosurgery

Background:

  • Primary hyperparathyroidism (pHPT) management guidelines recommend surgery or surveillance for asymptomatic patients.
  • Historically, it was believed most asymptomatic pHPT patients remain symptom-free.
  • Recent observations suggest symptom changes post-parathyroidectomy (PTX) in apparently asymptomatic individuals.

Purpose of the Study:

  • To investigate the prevalence of true asymptomatic pHPT in patients undergoing PTX.
  • To determine if preoperative factors predict asymptomatic status post-PTX.
  • To evaluate the benefits of PTX in patients initially presenting as asymptomatic.

Main Methods:

  • Retrospective cohort study of 582 consecutive pHPT patients (1987-1998).

Related Experiment Videos

  • Included 116 (20.9%) patients initially classified as asymptomatic.
  • Follow-up included validated questionnaires, physical exams, and lab tests at a median of 72 months post-PTX.

    • Main Results:

    • Only 9.3% of initially asymptomatic patients remained truly asymptomatic post-PTX (4.6% of the total cohort).
    • 81.4% of "asymptomatic" patients reported symptom improvement after PTX.
    • Multivariate analysis failed to identify predictors of postoperative asymptomatic status.

    Conclusions:

    • The majority of "asymptomatic" pHPT patients experience subjective benefits from PTX.
    • Truly asymptomatic pHPT is uncommon and unpredictable preoperatively.
    • PTX is recommended for all pHPT patients upon diagnosis, regardless of initial symptom presentation.